Ishikawa T, Chijiwa T, Hagiwara M, Mamiya S, Hidaka H
Department of Pharmacology, Nagoya University School of Medicine, Japan.
Mol Pharmacol. 1989 Jun;35(6):760-5.
The thyroid hormones have direct effects on vascular smooth muscle and are potent vasorelaxants. In the present study, the effects of d- and l-thyroxine (d-T4 and l-T4), 3,5,3'-triiodo-d-thyronine (d-T3), and 3,5,3'-triiodo-l-thyronine (l-T3) on the isolated mesenteric artery of the rabbit and superprecipitation of actomyosin from bovine aorta were examined. These thyroid hormones dose dependently relaxed vascular strips previously contracted with 50 mM KCl in the presence of phentolamine (1 microM), propranolol (1 microM), and atropine (0.3 microM), and the order of the inhibitory potency was l-T4 greater than d-T4 greater than l-T3 greater than d-T3 for the contraction. Pretreatment with l-T4 (10 and 30 microM) inhibited the contractile response concomitant with the inhibition of the 20,000-Da myosin light chain phosphorylation, without significant suppression of the increase in La3+-resistant 45Ca influx and uptake (5 and 30 min) induced by 50 mM KCl, suggesting that the inhibitory effect of l-T4 may not be primarily related to Ca2+ entry through the voltage-dependent Ca2+ channel. The l-T4 (10 and 30 microM) showed noncompetitive antagonism against the Ca2+-induced contraction in the high K+-depolarized vascular strips. Superprecipitation of actomyosin was inhibited by the addition of l-T4, in a dose-dependent manner, and calmodulin (1 microgram/ml) partly reversed the inhibitory effect of l-T4. Thyroid hormones were found to inhibit Ca2+/calmodulin-dependent smooth muscle myosin light chain kinase, and the Ki value for l-T4 was 2.5 microM. Although the concentrations of l-T4 used in this study are high, relative to circulating physiological levels, thyroid hormones act directly at the blood vessel wall to cause inhibition of the contractile process in vascular smooth muscle in vitro. Modulation of the 20,000-Da myosin light chain phosphorylation via the inhibition of myosin light chain kinase activity may at least in part contribute to the inhibitory effect of l-T4.
甲状腺激素对血管平滑肌有直接作用,是强效血管舒张剂。在本研究中,检测了d-和l-甲状腺素(d-T4和l-T4)、3,5,3'-三碘-d-甲状腺原氨酸(d-T3)和3,5,3'-三碘-l-甲状腺原氨酸(l-T3)对兔离体肠系膜动脉以及牛主动脉肌动球蛋白超沉淀的影响。这些甲状腺激素在酚妥拉明(1 microM)、普萘洛尔(1 microM)和阿托品(0.3 microM)存在的情况下,对先前用50 mM氯化钾收缩的血管条有剂量依赖性的舒张作用,对于收缩的抑制效力顺序为l-T4>d-T4>l-T3>d-T3。用l-T4(10和30 microM)预处理可抑制收缩反应,同时抑制20,000道尔顿肌球蛋白轻链磷酸化,而对50 mM氯化钾诱导的La3+抗性45Ca内流和摄取增加(5和30分钟)无明显抑制作用,这表明l-T4的抑制作用可能主要与通过电压依赖性Ca2+通道的Ca2+内流无关。l-T4(10和30 microM)对高钾去极化血管条中Ca2+诱导的收缩表现出非竞争性拮抗作用。l-T4的加入以剂量依赖性方式抑制肌动球蛋白的超沉淀,钙调蛋白(1微克/毫升)部分逆转l-T4的抑制作用。发现甲状腺激素可抑制Ca2+/钙调蛋白依赖性平滑肌肌球蛋白轻链激酶,l-T4的Ki值为2.5 microM。尽管本研究中使用的l-T4浓度相对于循环生理水平较高,但甲状腺激素在体外直接作用于血管壁,导致血管平滑肌收缩过程受到抑制。通过抑制肌球蛋白轻链激酶活性对20,000道尔顿肌球蛋白轻链磷酸化的调节可能至少部分有助于l-T4的抑制作用。